Smith Hunter C sold RYTM
February 1, 2026 · Form 4 insider transaction
Smith Hunter C sold 4,925 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,925
Price
$0.00
Total value
N/A
InsiderSmith Hunter C
Role—
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateFebruary 1, 2026
Filing dateFebruary 3, 2026
Shares owned after4,925
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.; The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.